MDT
MedtronicPrevious close
96.54
Change
−0.57 / −0.59%
P/E (TTM) ?
23.8
Market Cap
$124B
1M
+11.88%
S&P 500 −0.91% over same period
Volume / Avg Volume
8.7M / 10.8M
0.80× average
Latest earnings analysisFY2027 Q1Reported 2026-09-01
Medtronic FY27 Q1: revenue up 13.7%, EPS up 40.7%, guidance raised
Medtronic's fiscal 2027 first quarter was a beat-and-raise: revenue of $9.756 billion rose 13.7%, GAAP EPS jumped 40.7% to $1.14, and management lifted full-year organic growth and EPS guidance. The catch is a 53rd fiscal week that added roughly $570 million to revenue, so the underlying growth rate is lower than the headline. View: Bullish.
Read the full analysis →Revenue$9.76BYoY +13.70%
EPS (non-GAAP)$1.45
Next-day move+0.15%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2027 Q1 Quarter ended 2026-07 | 2026-09-01 | $9.8B | Read analysis → |
| FY2026 Q4 Quarter ended 2026-04 | 2026-06-03 | $36.4B | Pending |
| FY2026 Q3 Quarter ended 2026-01 | 2026-02-17 | $9.0B | Pending |
| FY2026 Q2 Quarter ended 2025-10 | 2025-11-18 | $9.0B | Pending |
| FY2026 Q1 Quarter ended 2025-07 | 2025-08-19 | $8.6B | Pending |
| FY2025 Q4 Quarter ended 2025-04 | 2025-05-21 | $33.5B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 14 of its 5-year rangeCheap
5-year range 21.7 – 30.3 · Median 26.4
Last 4 quarters: $1.2B in buybacks + $3.6B in dividends, 3.89% of market cap combined
P/E (TTM)
23.8
P/B
2.5
P/S
3.3
Dividend Yield
3.50%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.6% on average on the first trading day after, rising 4 times
Most recent +0.15%
Volatility & Correlation
1-year beta -0.20 · Correlation with S&P 500 -0.09Low beta
Annualized volatility 28% vs. 12% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $5.9MNet selling $5.9M
- 10-15Martha GeoffreyChairman and CEOSell$4.8M50,000 shares · Avg price 95.00
- 10-15Marinaro MichaelEVP, Pres MedSurg and AmericasSell$1.0M10,420 shares · Avg price 96.00
- 09-16KIIL HARRY SKIPEVP & President CardiovascularSell$0.14M1,483 shares · Avg price 93.65
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2027 Q1 | 9.76 | +13.7% | 65.0% | 1.47 | 1.14 |
| FY2026 Q4 | 9.81 | +9.9% | 65.4% | -3.56 | 0.96 |
| FY2026 Q3 | 9.02 | +8.7% | 63.8% | 1.14 | 0.89 |
| FY2026 Q2 | 8.96 | +6.6% | 65.8% | 1.37 | 1.07 |
| FY2026 Q1 | 8.58 | +8.4% | 65.0% | 1.04 | 0.81 |
| FY2025 Q4 | 8.93 | +3.9% | 64.8% | -3.61 | 0.81 |
| FY2025 Q3 | 8.29 | +2.5% | 66.5% | 1.29 | 1.01 |
| FY2025 Q2 | 8.40 | +5.2% | 64.9% | 1.27 | 0.99 |
| FY2025 Q1 | 7.92 | +2.8% | 65.1% | 1.04 | 0.80 |
| FY2024 Q4 | 8.59 | +0.5% | 64.5% | -3.02 | 0.50 |
| FY2024 Q3 | 8.09 | +4.7% | 65.6% | 1.32 | 0.99 |
| FY2024 Q2 | 7.98 | +5.3% | 65.4% | 0.91 | 0.68 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| MDT | 23.8 | +13.7% | 65.0% | +11.88% | Bullish |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |